Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in United States
274 trials · From ClinicalTrials.gov, checked 19 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleNBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 24
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04615013 - Phase 1/2Taking peopleA Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
- Where
- East Syracuse, Los Angeles, New York, Pittsburgh, Tucson
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05319730 · EU 2023-505189-26-00 - Phase 2Taking peopleChemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
- Where
- Houston
- Age
- 18 years to 79 years
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03161522 - No phaseTaking peopleDyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers
- Where
- Houston
- Age
- 18 years and over
- People
- 400
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03948100 - Phase 2Taking peopleOral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma
- Where
- Cleveland
- Age
- 18 years and over
- People
- 25
- Run by
- Melissa Lumish
See details and how to joinNCT06044311 - Phase 2Taking peopleComparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 50
- Run by
- Mayo Clinic
See details and how to joinNCT06265285 - Phase 2Taking peoplePreoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
- Where
- Jacksonville, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 99
- Run by
- Mayo Clinic
See details and how to joinNCT06078709 - Phase 1/2Taking people177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Where
- Dothan, Grand Rapids, Houston, Omaha
- Age
- 18 years and over
- People
- 61
- Run by
- Radiopharm Theranostics, Ltd
See details and how to joinNCT07189871 - Phase 2Taking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Commack, Houston, Louisville, Orange, Palo Alto, Providence, Santa Rosa
- Age
- 18 years and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - Phase 1Taking peopleA First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- Where
- Columbus, Fairfax, Farmington Hills, Grand Rapids, Houston, La Jolla, Morristown, Portland, Santa Monica, Spokane, Tampa, West Valley City
- Age
- 18 years and over
- People
- 170
- Run by
- ALX Oncology Inc.
See details and how to joinNCT07085091 - Phase 1Taking peopleA Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
- Where
- Fairfax, Maumee, Portland
- Age
- 18 years and over
- People
- 74
- Run by
- TwoStep Therapeutics, Inc.
See details and how to joinNCT07814248 - Phase 3Not yet taking people in United StatesPhase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
- Where
- Boston, Dallas, Denver, Detroit, Houston, Los Angeles, Madison, Nashville, New Haven, New York, Phoenix, Portland
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Akeso
See details and how to joinNCT07700979 - Phase 1/2Taking peopleSpevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Where
- Boston, Denver, Duarte, Durham, Fairfax, Houston, Iowa City, Los Angeles, Louisville, Madison, Pittsburgh
- Age
- 18 years and over
- People
- 350
- Run by
- Phanes Therapeutics
See details and how to joinNCT05482893 - Phase 1Taking peopleIKS014 in Advanced Solid Tumors That Express HER2
- Where
- Boston, Fort Worth, Nashville, Newport Beach
- Age
- 18 years and over
- People
- 165 worldwide
- Run by
- Iksuda Therapeutics Ltd.
See details and how to joinNCT05872295 - Phase 1/2Taking peopleStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Where
- Jacksonville, New York, Rochester
- Age
- 18 years and over
- People
- 392 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06005493 · EU 2023-504139-42-00 - No phaseTaking peopleDESTINY-PANTUMOUR04
- Where
- Birmingham, Boulder, Bullhead City, Canton, Casa Grande, Coral Springs, Dallas, Decatur, Durham, Farmington, Maumee, Nashville, Philadelphia, San Diego, St. Petersburg, Topeka, West Palm Beach, Wilson
- Age
- 18 years to 130 years
- People
- 100
- Run by
- AstraZeneca
See details and how to joinNCT07124000 - Phase 1/2Taking peopleClinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- Where
- Boston, Nashville
- Age
- 18 years and over
- People
- 147 worldwide
- Run by
- Yuhan Corporation
See details and how to joinNCT05523947 - Phase 1/2Taking peopleSafety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Where
- Beverly Hills, Boston, Boynton Beach, Dallas, Glendale, Los Angeles, Nashville, Tacoma
- Age
- 18 years and over
- People
- 134
- Run by
- Neonc Technologies, Inc.
See details and how to joinNCT06047379 - No phaseTaking peoplePan-tumor MRD Study
- Where
- Atlanta, Binghamton, Birmingham, Bullhead City, Canton, Casa Grande, Charlotte, Coral Springs, Corbin, Covington, Elizabethtown, Englewood, Farmington, Glendale, Goldsboro, Grand Rapids, Houston, Kingwood, Lancaster, Lexington, Lincoln, Little Rock, Louisville, Maumee, O'Fallon, Orange City, Oxnard, Portland, Richmond, Rochester, San Diego, Sayre, Shirley, Shreveport, Springdale, Springfield, Stockton, St. Petersburg, Tacoma, Texarkana, Topeka, Tulsa, Urbana, Wichita, Wilson, York
- Age
- 18 years and over
- People
- 1,350
- Run by
- Paradigm Health
See details and how to joinNCT06605404 - Phase 1Taking peopleA Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- New Have, Santa Monica
- Age
- 18 years and over
- People
- 76 worldwide
- Run by
- Kivu Bioscience Inc.
See details and how to joinNCT07229313 - Phase 2Taking peoplesFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
- Where
- Hamilton, Lakewood, Long Branch, Newark, New Brunswick
- Age
- 18 years and over
- People
- 38
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT05332002 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Albuquerque, Boston, Cincinnati, Columbus, Commack, East Brunswick, Grand Rapids, Houston, Kansas City, Los Angeles, Madison, Muncie, Nashville, Portland, San Diego, Santa Rosa
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - Phase 2Taking peopleA Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 37
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07631000 - Phase 2Not yet taking people in United StatesPhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCC
- Where
- Nashville
- Age
- 18 years to 100 years
- People
- 20
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT07836049 - Phase 1/2Taking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Aurora, Boston, Dallas, Detroit, Duarte, Fairfax, Grand Rapids, Houston, Indianapolis, Irving, Nashville, New York, Oklahoma City, Orange, Pittsburgh, Sacramento, San Antonio, Sarasota, Stanford, Tampa
- Age
- 18 years and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551